

share
Aprikalim CAS NO 89544-10-5
Unit Price:
CAS No.:89544-10-5
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Aprikalim CAS NO 89544-10-5 is a selective potassium channel opener belonging to the cyanoguanidine class of compounds. This compound is of significant interest in pharmacological research due to its role as a vasodilator and cardioprotective agent. It is primarily utilized by pharmaceutical R&D laboratories, academic research institutions, and fine chemical manufacturers engaged in cardiovascular drug discovery and development.
Application
- Cardiovascular Research: Used as a reference standard and active agent in studies investigating potassium channel function, vasodilation, and myocardial preconditioning.
- Pharmaceutical Development: Serves as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel cardioprotective and antihypertensive drug candidates.
- Biochemical Assays: Employed in in vitro and in vivo models to study smooth muscle relaxation and cellular signaling pathways involving ATP-sensitive potassium (KATP) channels.
- Reference Standard: Provides a high-purity compound for analytical method development, validation, and quality control in regulatory submissions.
Basic Information
| Product Name | Aprikalim |
| CAS No. | 89544-10-5 |
| Molecular Formula | C11H13N5O |
| Molecular Weight | 231.25 g/mol |
| Synonyms | N-Cyano-N'-(1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)-N''-1,1-dimethylethylguanidine; BRL 38227; Aprikalim; Potassium channel opener BRL 38227; 6-Cyano-1-[(tert-butylamino)methyl]-1,2,3,4-tetrahydroquinolin-2-one |
| EINECS | Contact for details |
Quality Control
Our Aprikalim is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, IR and NMR for structural confirmation, and residual solvent analysis. We provide full traceability and Certificates of Analysis (COA) are available for all shipments, ensuring compliance with research and development grade specifications.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to maintain stability.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification (IR) | Conforms to reference spectrum |
| Identification (HPLC) | Retention time corresponds to reference standard |
| Purity (HPLC) | ≥ 98.0% |
| Water Content (KF) | ≤ 1.0% |
| Residue on Ignition | ≤ 0.1% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Phentolamine Mesilate CAS NO 65-28-1


Fasudil Hydrochloride CAS NO 105628-07-7


Nicoboxil CAS NO 13912-80-6


Papaverine Nitrite CAS NO 132-40-1


Prospasmin CAS NO 132-45-6


Dl-Phenylephrine Hydrochloride CAS NO 154-86-9


1H-Purine-2,6-Dione,7-Butyl-3,7-Dihydro-1,3-Dimethyl- CAS NO 1021-65-4


Moxaverine Hydrochloride CAS NO 1163-37-7


Sodium Tetradecyl Sulfate CAS NO 1191-50-0


Gapicomine CAS NO 1539-39-5


Nicametate Citrate CAS NO 1641-74-3


Cinnamaverine CAS NO 1679-75-0


1,2,3,6-Tetrahydro-1,3-Dimethyl-2,6-Dioxo-7H-Purine-7-Acetic Acid, Compound With 7-[2-(Dimethylamino)Ethoxy]-2-Phenyl-4H-1-Benzopyran-4-One (1:1) CAS NO 1715-55-5


Pimefylline CAS NO 10001-43-1


Tribenoside CAS NO 10310-32-4


Podilfen CAS NO 13409-53-5


Pargeverine Hcl CAS NO 13479-13-5


Carpronium CAS NO 14075-13-9


Cetiedil CAS NO 14176-10-4


Bencyclane Fumarate CAS NO 14286-84-1
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






